CGT
IRWD icon

Capital Guardian Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

Capital Guardian Trust’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,313
Closed -$17K – 780
2014
Q4 		$17K Sell
1,313
-647,878
-100% -$7.41M ﹤0.01% 454
2014
Q3 		$7.04M Sell
649,191
-13,542
-2% -$155K 0.05% 188
2014
Q2 		$8.51M Sell
662,733
-854,522
-56% -$9.29M 0.06% 176
2014
Q1 		$15.7M Sell
1,517,255
-806,775
-35% -$9.07M 0.11% 147
2013
Q4 		$22.6M Sell
2,324,030
-547,331
-19% -$4.91M 0.15% 127
2013
Q3 		$28.5M Buy
2,871,361
+89,803
+3% +$881K 0.2% 107
2013
Q2 		$23.2M Buy
+2,781,558
New +$33.7M 0.16% 122

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Guardian Trust's IRWD Position: Q1 2015 in Review

Capital Guardian Trust sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2015, closing a stake of 1,313 shares — an estimated $17K sold.

Capital Guardian Trust first reported a position in IRWD in Q2 2013 and held it in 7 quarters. The position peaked at $28.5M in Q3 2013. 142 funds tracked by Wall St. Rank hold IRWD as of Q1 2015.

  • Capital Guardian Trust reported no remaining Ironwood Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Capital Guardian Trust sold 1,313 Ironwood Pharmaceuticals shares in Q1 2015, an estimated $17K.
  • Capital Guardian Trust first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Capital Guardian Trust's Ironwood Pharmaceuticals position peaked at $28.5M in Q3 2013.
  • 142 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2015.

Based on Capital Guardian Trust's 13F filing for Q1 2015, filed 15 May 2015.